InvestorsHub Logo
Followers 40
Posts 3890
Boards Moderated 0
Alias Born 09/30/2010

Re: Elcappy1 post# 3124

Wednesday, 04/08/2020 6:59:06 AM

Wednesday, April 08, 2020 6:59:06 AM

Post# of 3729
love this, thx.

About Captisol®

Captisol is a patent-protected, chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs. Captisol was invented and initially developed by scientists in the laboratories of Dr. Valentino Stella, University Distinguished Professor at the University of Kansas’ Higuchi Biosciences Center for specific use in drug development and formulation. This unique technology has enabled several FDA-approved products, including Amgen’s KYPROLIS®, Baxter International’s NEXTERONE®, Acrotech Biopharma L.L.C.’s and CASI Pharmaceuticals’ EVOMELA®, Melinta Therapeutics’ BAXDELA™ and Sage Therapeutics’ ZULRESSO™. There are many Captisol-enabled products currently in various stages of development.


https://www.ligand.com/news-events/press-releases/detail/403/ligands-technologies-support-and-enable-potential
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LGND News